About Douglas Kahn
Form D filings for CytoTronics in 2024 list Douglas Kahn as director.
Douglas Kahn first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Douglas Kahn in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Douglas Kahn works with at each company, as listed on that company's latest Form D.
CytoTronics, Inc. · Form D, Oct 11, 2024
SR
Sameer Rohatgi
Director
JA
Jeffrey Abbott
Chief Executive Officer and director
WW
Wenxuan Wu
Executive officer and director
JA
Jenna Abelli
Director